Sadeghi Mohammad Amin, Stevens Daniel, Kundu Shinjini, Sanghera Rohan, Dagher Richard, Yedavalli Vivek, Jones Craig, Sair Haris, Luna Licia P
Division of Neuroradiology, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medicine, 600 N Wolfe St, Phipps B100F, Baltimore, MD, 21287, USA.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Imaging Inform Med. 2024 Dec;37(6):2768-2783. doi: 10.1007/s10278-024-01101-1. Epub 2024 May 23.
Early, accurate diagnosis of neurodegenerative dementia subtypes such as Alzheimer's disease (AD) and frontotemporal dementia (FTD) is crucial for the effectiveness of their treatments. However, distinguishing these conditions becomes challenging when symptoms overlap or the conditions present atypically. Resting-state fMRI (rs-fMRI) studies have demonstrated condition-specific alterations in AD, FTD, and mild cognitive impairment (MCI) compared to healthy controls (HC). Here, we used machine learning to build a diagnostic classification model based on these alterations. We curated all rs-fMRIs and their corresponding clinical information from the ADNI and FTLDNI databases. Imaging data underwent preprocessing, time course extraction, and feature extraction in preparation for the analyses. The imaging features data and clinical variables were fed into gradient-boosted decision trees with fivefold nested cross-validation to build models that classified four groups: AD, FTD, HC, and MCI. The mean and 95% confidence intervals for model performance metrics were calculated using the unseen test sets in the cross-validation rounds. The model built using only imaging features achieved 74.4% mean balanced accuracy, 0.94 mean macro-averaged AUC, and 0.73 mean macro-averaged F1 score. It accurately classified FTD (F1 = 0.99), HC (F1 = 0.99), and MCI (F1 = 0.86) fMRIs but mostly misclassified AD scans as MCI (F1 = 0.08). Adding clinical variables to model inputs raised balanced accuracy to 91.1%, macro-averaged AUC to 0.99, macro-averaged F1 score to 0.92, and improved AD classification accuracy (F1 = 0.74). In conclusion, a multimodal model based on rs-fMRI and clinical data accurately differentiates AD-MCI vs. FTD vs. HC.
对神经退行性痴呆亚型(如阿尔茨海默病(AD)和额颞叶痴呆(FTD))进行早期、准确的诊断对于其治疗效果至关重要。然而,当症状重叠或病情表现不典型时,区分这些病症就变得具有挑战性。静息态功能磁共振成像(rs-fMRI)研究表明,与健康对照(HC)相比,AD、FTD和轻度认知障碍(MCI)存在特定病症的改变。在此,我们使用机器学习基于这些改变构建了一个诊断分类模型。我们从ADNI和FTLDNI数据库中整理了所有rs-fMRI及其相应的临床信息。成像数据经过预处理、时间序列提取和特征提取,为分析做准备。将成像特征数据和临床变量输入具有五重嵌套交叉验证的梯度提升决策树,以构建对四组进行分类的模型:AD、FTD、HC和MCI。使用交叉验证轮次中的未见过的测试集计算模型性能指标的平均值和95%置信区间。仅使用成像特征构建的模型平均平衡准确率达到74.4%,平均宏平均AUC为0.94,平均宏平均F1分数为0.73。它能准确地对FTD(F1 = 0.99)、HC(F1 = 0.99)和MCI(F1 = 0.86)的fMRI进行分类,但大多将AD扫描误分类为MCI(F1 = 0.08)。在模型输入中添加临床变量可将平衡准确率提高到91.1%,宏平均AUC提高到0.99,宏平均F1分数提高到0.92,并提高AD分类准确率(F1 = 0.74)。总之,基于rs-fMRI和临床数据的多模态模型能够准确区分AD-MCI与FTD与HC。